Growth Equity
Growth Credit
Healthcare
Contact
Menu
Investor Log in
Close
Growth Equity
Growth Credit
Healthcare
Contact
About Us
Team
Careers
Insights
Portfolio
Investors
Home
/
Insights
/
No nit picking: Head lice group Hatchtech gets green light to trials
No nit picking: Head lice group Hatchtech gets green light to trials
01 February 2018
Posted in —
OneVentures
,
News
Share
Linkedin
Twitter
Copy Link
Learn More
Share
Linkedin
Twitter
Copy Link
You may also like
02 August 2020
OneVentures
FDA Approves Xeglyze™ for the topical treatment of head lice infestation
02 August 2020
OneVentures
Hatchtech gets lice treatment nod from FDA
21 October 2014
OneVentures
Hatchtech announces successful results from Phase 2 ovicidal study
View All
Ventured. Gained.
